NeoGenomics
NEO
#5098
Rank
โ‚ฌ1.39 B
Marketcap
10,80ย โ‚ฌ
Share price
-1.23%
Change (1 day)
-24.82%
Change (1 year)

Market capitalization of NeoGenomics (NEO)

Market cap: โ‚ฌ1.39 Billion

As of January 2026 NeoGenomics has a market cap of โ‚ฌ1.39 Billion. This makes NeoGenomics the world's 5098th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NeoGenomics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.39 B3.33%
2025โ‚ฌ1.35 B-34.85%
2024โ‚ฌ2.07 B11.27%
2023โ‚ฌ1.86 B71.48%
2022โ‚ฌ1.08 B-70.67%
2021โ‚ฌ3.70 B-23.68%
2020โ‚ฌ4.86 B77.64%
2019โ‚ฌ2.73 B162.75%
2018โ‚ฌ1.04 B75.37%
2017โ‚ฌ0.59 B-7.18%
2016โ‚ฌ0.63 B17.22%
2015โ‚ฌ0.54 B164.21%
2014โ‚ฌ0.20 B60.43%
2013โ‚ฌ0.12 B51.66%
2012โ‚ฌ84.89 M82.13%
2011โ‚ฌ46.61 M27.43%
2010โ‚ฌ36.57 M-6.05%
2009โ‚ฌ38.93 M181.35%
2008โ‚ฌ13.83 M-40.41%
2007โ‚ฌ23.21 M-24.52%
2006โ‚ฌ30.76 M739.88%
2005โ‚ฌ3.66 M-7.73%
2004โ‚ฌ3.96 M441.79%
2003โ‚ฌ0.73 M-78.64%
2002โ‚ฌ3.43 M-50.13%
2001โ‚ฌ6.87 M-36.99%
2000โ‚ฌ10.91 M

End of Day market cap according to different sources

On Jan 25th, 2026 the market cap of NeoGenomics was reported to be:

โ‚ฌ1.39 Billion
by Nasdaq info icon info icon
โ‚ฌ1.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
RadNet
RDNT
โ‚ฌ4.76 B 241.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚ฌ13.27 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ17.06 B 1,121.28%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ18.68 B 1,236.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ30.85 M-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA